Insurers And Government Are Slow To Cover Expensive CAR-T Cancer Therapy

Some critically ill patients who received a CAR-T cell treatment have remained cancer-free for as long as five years, researchers say. But the price is high.

Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren’t paying for the treatment, and Medicare’s complicated payment rates have hospitals worried.

(Image credit: Fanatic Studio/Collection Mix: Subjects RF/Getty Images)

Read the full post on Health Care : NPR

Michelle Andrews